| Bioactivity | BML264 ((E)-N-(p-amylcinnamoyl) anthranilic acid) is an agonist for TREK-1. BML264 can be used to study diseases associated with TASK1 dysfunction[1]. |
| CAS | 99196-74-4 |
| Formula | C21H23NO3 |
| Molar Mass | 337.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Feinmark S, et al., Method of treating a condition associated with phosphorylation of TASK-1. US20070259051 A1. |